United States · FDA National Drug Code directory
Levocetirizine Dihydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-312_2e504864-a08d-48e1-e063-6394a90a92ed
- Product NDC
- 42571-312
- Form
- TABLET
- Composition / generic term
- Levocetirizine Dihydrochloride
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190201
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (42571-312-11) / 10 TABLET in 1 BLISTER PACK (42571-312-32) · 42571-312-11
- 1 BOTTLE in 1 CARTON (42571-312-18) / 10 TABLET in 1 BOTTLE · 42571-312-18
- 2500 TABLET in 1 POUCH (42571-312-53) · 42571-312-53
- 1 BOTTLE in 1 CARTON (42571-312-90) / 90 TABLET in 1 BOTTLE · 42571-312-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →